Grifols product portfolio

Since 1909, Grifols has been dedicated to developing high-quality products and services that enhance the health and well-being of people worldwide. We are committed to listening to and learning from our clients to ensure that their patients receive the best possible treatments.

Our ongoing R+D+i efforts enable us to offer a broad portfolio of innovative products and services, delivered through our main divisions.

Consult here our product catalog:

Select your country or region
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Czech Republic
  • Dubai
  • France
  • Germany
  • Hong Kong SAR
  • Italy
  • Japan
  • Malaysia
  • Mexico
  • Nordic Countries
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • Spain
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States

The product information for this country is also available in other languages. Please, Select your preferred language:

Select your language
    Bio Supplies
    • Immunology and Neurology
    • Intensive care
    • Inclusiv Compounding Portfolio
      • Robotics and other compounding devices

    Order by: Newest A-Z

    View All|0 results have been found

    Learn more about our 4 divisions:


    Dedicated to the research, development, production and commercialization of plasma-derived medicines.


    Specialized in the research, development, production and commercialization of diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis and prognosis to disease and treatment monitoring–to serve professionals working in transfusion medicine and clinical diagnostics.


    Focused on products and services designed to meet the needs of pharmacies for safety, efficiency and regulatory compliance. Also delivers solutions for clinical nutrition, intravenous therapy and medical devices used in hospitals, within the range of inclusiv and medication management.

    Bio Supplies

    Supplying high-quality biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products.